This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Massimiliano Codispoti Pankaj Mankad Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Codispoti, M. Articles by Mankad, P. Search for Related Content PubMed PubMed Citation Articles by Codispoti, M. Articles by Mankad, P. Related Collections Myocardial protection

Optimal myocardial protection strategy for coronary artery bypass grafting without cardioplegia: prospective randomised trial

Department of Cardiac Surgery, Royal Infirmary, Edinburgh, EH16 4SA, UK

*Corresponding author. Tel.: +44 131 242 3902; fax: +44 131 242 3929.

E-mail address: pankaj.mankad{at}luht.scot.nhs.uk (P. Mankad).

Although hypothermia and ischaemic preconditioning (IP) are independently recognised mechanisms of cardioprotection, interactions between myocardial temperature and preconditioning have not been investigated. Therefore, this study explored the possibility of inducing IP during hypothermia and quantifying its effects at two temperature regimens commonly used in clinical practice. One hundred and four patients undergoing coronary artery bypass grafting (CABG) with intermittent cross-clamping and ventricular fibrillation were randomised to four groups: N=normothermia (36.5±0.5 °C); NP=normothermia+preconditioning, H=hypothermia (31.5±0.5 °C), HP=hypothermia+preconditioning. The primary outcome measure was release of cardiac Troponin I (cTnI), measured at 6 time points from pre- to 72 h after the end of CPB. There were no hospital deaths and no significant differences in pre- and intra-operative variables (P0.05). There were significant differences in cTnI release between all groups, as follows: N: 117±12 µg/l (P0.05 vs. all groups), NP: 87±8 µg/l (P0.05 vs. groups N and HP), H: 76±6 µg/l (P0.05 vs. groups N and HP), HP: 44±6 µg/l (P0.05 vs. all groups). In conclusion, IP can be induced at both normothermia and moderate hypothermia, where it significantly reduces myocardial damage. Further studies are warranted to investigate the effects of the addition of hypothermia to pharmacological myocardial preconditioning.

Key Words: Ischaemic preconditioning; Temperature; Coronary artery bypass grafting